ANI Pharmaceuticals | ANIP - Umlaufvermögen

Aktienkurs
74.67
Täglich Wechseln
-0.15 -0.20%
Monatlich
-0.57%
Jährlich
16.20%
Q1 Prognose
72.43




Umlaufvermögen Veränderung Datum
AbbVie USD 29.06B 523M 2025-12
ANI Pharmaceuticals USD 753.12M 54.72M 2025-12
Assertio Holdings USD 263.57M 53.36M 2025-09
Aurora Cannabis CAD 445.84M 22M 2025-12
Canopy Growth CAD 524.67M 78.85M 2025-12
Eli Lilly USD 55.63B 6.44B 2025-12
Emergent BioSolutions USD 679.5M 41.3M 2023-12
Heron Therapeutics USD 238.07M 8.67M 2025-12
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Nektar Therapeutics USD 281.36M 94.79M 2025-09
Novartis USD 30.46B 2.26B 2025-12
Omeros USD 69.65M 26.53M 2025-06
Perrigo USD 2.8B 81.8M 2025-12
Sun Pharmaceuticals INR 601.36B 75.42B 2025-09
Teva Pharmaceutical Industries USD 13.95B 1.21B 2025-12